| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jan 25 | NAMS NewAmsterdam Pharma | Ordinary Shares | Grant | Acquire A | No | No | 0 | 123,529 | 0.00 | 123,529 |
| 6 Jan 25 | NAMS NewAmsterdam Pharma | Option Ordinary Shares | Grant | Acquire A | No | No | 25.85 | 670,467 | 17.33 mm | 670,467 |
| 2 Jan 25 | SLN Silence Therapeutics | Share Option Ordinary Shares | Grant | Acquire A | No | No | 2.4 | 48,000 | 115.20 k | 48,000 |
| 10 Dec 24 | TENX Tenax Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.94 | 100,000 | 594.00 k | 100,000 |
| 9 Oct 24 | NAMS NewAmsterdam Pharma | Warrant Ordinary Shares | Gift | Dispose G | No | No | 11.5 | 15,000 | 172.50 k | 85,000 |
